Mesoblast Limited
MESO
$16.11
$0.090.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 191.39% | 68.54% | -39.71% | -39.92% | -37.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 191.39% | 68.54% | -39.71% | -39.92% | -37.47% |
| Cost of Revenue | 0.56% | -16.79% | -49.28% | -47.18% | -41.79% |
| Gross Profit | 32.75% | 34.64% | 51.50% | 48.53% | 42.49% |
| SG&A Expenses | 57.36% | 46.33% | 2.35% | -9.11% | -21.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 148.05% | 134.53% | 101.63% | 95.26% | 88.10% |
| Total Operating Expenses | 24.68% | 0.30% | -31.95% | -33.26% | -31.40% |
| Operating Income | -7.71% | 7.25% | 30.97% | 32.47% | 30.71% |
| Income Before Tax | -15.50% | -24.49% | -12.34% | 4.44% | 12.51% |
| Income Tax Expenses | 272.77% | 221.45% | 152.56% | 86.61% | 25.97% |
| Earnings from Continuing Operations | -16.13% | -25.05% | -12.76% | 4.23% | 12.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.13% | -25.05% | -12.76% | 4.23% | 12.47% |
| EBIT | -7.71% | 7.25% | 30.97% | 32.47% | 30.71% |
| EBITDA | -3.75% | 9.36% | 31.03% | 32.43% | 30.45% |
| EPS Basic | 3.42% | -3.27% | 16.76% | 27.54% | 32.56% |
| Normalized Basic EPS | 8.13% | 7.93% | 31.03% | 39.66% | 45.27% |
| EPS Diluted | 3.42% | -3.27% | 16.83% | 27.59% | 32.62% |
| Normalized Diluted EPS | 8.13% | 7.93% | 31.03% | 39.66% | 45.27% |
| Average Basic Shares Outstanding | 22.41% | 22.82% | 7.56% | 3.76% | 1.68% |
| Average Diluted Shares Outstanding | 22.41% | 22.82% | 7.56% | 3.76% | 1.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |